In conclusion, there is compelling evidence that the BM microenvironment-mediated expression of several TFs, such as c-MYC, JunB and c-MAF, and the modulation of chromatin condensation can mediate drug resistance in MM, envisioning a possible targeting of these molecules in the anti-MM armamentarium. The gene discussed is JUNB; the disease is Miyoshi myopathy.